DR ING HC F PORSCHE AG (P911.DE) Stock Fundamental Analysis

Europe • Frankfurt Stock Exchange • FRA:P911 • DE000PAG9113

39.91 EUR
-0.88 (-2.16%)
Last: Feb 3, 2026, 05:29 PM
Fundamental Rating

5

P911 gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 33 industry peers in the Automobiles industry. P911 has an excellent profitability rating, but there are some minor concerns on its financial health. P911 is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • In the past year P911 was profitable.
  • P911 had a positive operating cash flow in the past year.
  • P911 had positive earnings in each of the past 5 years.
  • P911 had a positive operating cash flow in each of the past 5 years.
P911.DE Yearly Net Income VS EBIT VS OCF VS FCFP911.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

1.2 Ratios

  • P911 has a better Return On Assets (3.88%) than 84.85% of its industry peers.
  • P911 has a Return On Equity of 9.19%. This is in the better half of the industry: P911 outperforms 78.79% of its industry peers.
  • P911 has a better Return On Invested Capital (6.83%) than 81.82% of its industry peers.
  • P911 had an Average Return On Invested Capital over the past 3 years of 13.25%. This is significantly above the industry average of 5.93%.
  • The last Return On Invested Capital (6.83%) for P911 is well below the 3 year average (13.25%), which needs to be investigated, but indicates that P911 had better years and this may not be a problem.
Industry RankSector Rank
ROA 3.88%
ROE 9.19%
ROIC 6.83%
ROA(3y)9.11%
ROA(5y)8.43%
ROE(3y)22.84%
ROE(5y)20.35%
ROIC(3y)13.25%
ROIC(5y)11.73%
P911.DE Yearly ROA, ROE, ROICP911.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

  • Looking at the Profit Margin, with a value of 3.69%, P911 is in the better half of the industry, outperforming 69.70% of the companies in the same industry.
  • P911's Profit Margin has declined in the last couple of years.
  • Looking at the Operating Margin, with a value of 6.64%, P911 is in the better half of the industry, outperforming 75.76% of the companies in the same industry.
  • In the last couple of years the Operating Margin of P911 has declined.
  • P911's Gross Margin of 18.85% is fine compared to the rest of the industry. P911 outperforms 60.61% of its industry peers.
  • In the last couple of years the Gross Margin of P911 has remained more or less at the same level.
Industry RankSector Rank
OM 6.64%
PM (TTM) 3.69%
GM 18.85%
OM growth 3Y-3.68%
OM growth 5Y-1.89%
PM growth 3Y-9.69%
PM growth 5Y-1.78%
GM growth 3Y-0.89%
GM growth 5Y0.39%
P911.DE Yearly Profit, Operating, Gross MarginsP911.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

5

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so P911 is creating value.
  • P911 has about the same amout of shares outstanding than it did 1 year ago.
  • The number of shares outstanding for P911 remains at a similar level compared to 5 years ago.
  • P911 has a worse debt/assets ratio than last year.
P911.DE Yearly Shares OutstandingP911.DE Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
P911.DE Yearly Total Debt VS Total AssetsP911.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

2.2 Solvency

  • P911 has a debt to FCF ratio of 5.28. This is a neutral value as P911 would need 5.28 years to pay back of all of its debts.
  • P911 has a better Debt to FCF ratio (5.28) than 81.82% of its industry peers.
  • A Debt/Equity ratio of 0.29 indicates that P911 is not too dependend on debt financing.
  • P911 has a Debt to Equity ratio of 0.29. This is amongst the best in the industry. P911 outperforms 84.85% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF 5.28
Altman-Z N/A
ROIC/WACC1.09
WACC6.26%
P911.DE Yearly LT Debt VS Equity VS FCFP911.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.3 Liquidity

  • A Current Ratio of 1.35 indicates that P911 should not have too much problems paying its short term obligations.
  • P911 has a better Current ratio (1.35) than 78.79% of its industry peers.
  • P911 has a Quick Ratio of 1.35. This is a bad value and indicates that P911 is not financially healthy enough and could expect problems in meeting its short term obligations.
  • P911's Quick ratio of 0.96 is fine compared to the rest of the industry. P911 outperforms 69.70% of its industry peers.
Industry RankSector Rank
Current Ratio 1.35
Quick Ratio 0.96
P911.DE Yearly Current Assets VS Current LiabilitesP911.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2

3. Growth

3.1 Past

  • The earnings per share for P911 have decreased strongly by -30.27% in the last year.
  • The Earnings Per Share has been growing slightly by 5.12% on average over the past years.
  • P911 shows a decrease in Revenue. In the last year, the revenue decreased by -1.10%.
  • The Revenue has been growing slightly by 7.05% on average over the past years.
EPS 1Y (TTM)-30.27%
EPS 3Y-3.83%
EPS 5Y5.12%
EPS Q2Q%-198.51%
Revenue 1Y (TTM)-1.1%
Revenue growth 3Y6.55%
Revenue growth 5Y7.05%
Sales Q2Q%-4.39%

3.2 Future

  • P911 is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -0.33% yearly.
  • The Revenue is expected to grow by 2.96% on average over the next years.
EPS Next Y-83.94%
EPS Next 2Y-22.77%
EPS Next 3Y-10.58%
EPS Next 5Y-0.33%
Revenue Next Year-5.99%
Revenue Next 2Y-2.46%
Revenue Next 3Y-0.75%
Revenue Next 5Y2.96%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
P911.DE Yearly Revenue VS EstimatesP911.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 10B 20B 30B 40B 50B
P911.DE Yearly EPS VS EstimatesP911.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 1 2 3 4 5

5

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 10.13, which indicates a very decent valuation of P911.
  • Based on the Price/Earnings ratio, P911 is valued a bit cheaper than 66.67% of the companies in the same industry.
  • P911's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.41.
  • A Price/Forward Earnings ratio of 16.98 indicates a correct valuation of P911.
  • P911's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. P911 is more expensive than 60.61% of the companies in the same industry.
  • P911 is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 25.64, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 10.13
Fwd PE 16.98
P911.DE Price Earnings VS Forward Price EarningsP911.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 90.91% of the companies in the same industry are more expensive than P911, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, P911 is valued a bit cheaper than the industry average as 66.67% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 8.4
EV/EBITDA 1.18
P911.DE Per share dataP911.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

  • The decent profitability rating of P911 may justify a higher PE ratio.
  • P911's earnings are expected to decrease with -10.58% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)1.98
EPS Next 2Y-22.77%
EPS Next 3Y-10.58%

4

5. Dividend

5.1 Amount

  • P911 has a Yearly Dividend Yield of 5.60%, which is a nice return.
  • P911's Dividend Yield is a higher than the industry average which is at 3.62.
  • P911's Dividend Yield is rather good when compared to the S&P500 average which is at 1.83.
Industry RankSector Rank
Dividend Yield 5.6%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years2
P911.DE Yearly Dividends per shareP911.DE Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

  • 100.96% of the earnings are spent on dividend by P911. This is not a sustainable payout ratio.
DP100.96%
EPS Next 2Y-22.77%
EPS Next 3Y-10.58%
P911.DE Yearly Income VS Free CF VS DividendP911.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B
P911.DE Dividend Payout.P911.DE Dividend Payout, showing the Payout Ratio.P911.DE Dividend Payout.PayoutRetained Earnings

DR ING HC F PORSCHE AG

FRA:P911 (2/3/2026, 5:29:45 PM)

39.91

-0.88 (-2.16%)

Chartmill FA Rating
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobiles
Earnings (Last)10-10
Earnings (Next)03-11
Inst Owners11.43%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap18.18B
Revenue(TTM)56.35B
Net Income(TTM)2.08B
Analysts53.75
Price Target46.29 (15.99%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.6%
Yearly Dividend2.31
Dividend Growth(5Y)N/A
DP100.96%
Div Incr Years1
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-98.95%
Min EPS beat(2)-263.81%
Max EPS beat(2)65.91%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-5.24%
Min Revenue beat(2)-9.69%
Max Revenue beat(2)-0.79%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.14%
PT rev (3m)4.59%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-9.64%
EPS NY rev (1m)-1.33%
EPS NY rev (3m)-62.74%
Revenue NQ rev (1m)-1%
Revenue NQ rev (3m)5.01%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.42%
Valuation
Industry RankSector Rank
PE 10.13
Fwd PE 16.98
P/S 0.32
P/FCF 8.4
P/OCF 3.75
P/B 0.8
P/tB 1.26
EV/EBITDA 1.18
EPS(TTM)3.94
EY9.87%
EPS(NY)2.35
Fwd EY5.89%
FCF(TTM)4.75
FCFY11.9%
OCF(TTM)10.64
OCFY26.66%
SpS123.71
BVpS49.69
TBVpS31.71
PEG (NY)N/A
PEG (5Y)1.98
Graham Number66.37
Profitability
Industry RankSector Rank
ROA 3.88%
ROE 9.19%
ROCE 9.85%
ROIC 6.83%
ROICexc 10.13%
ROICexgc 14.89%
OM 6.64%
PM (TTM) 3.69%
GM 18.85%
FCFM 3.84%
ROA(3y)9.11%
ROA(5y)8.43%
ROE(3y)22.84%
ROE(5y)20.35%
ROIC(3y)13.25%
ROIC(5y)11.73%
ROICexc(3y)18.5%
ROICexc(5y)16.21%
ROICexgc(3y)27.68%
ROICexgc(5y)23.14%
ROCE(3y)19.1%
ROCE(5y)16.92%
ROICexgc growth 3Y2.85%
ROICexgc growth 5Y3.55%
ROICexc growth 3Y-0.44%
ROICexc growth 5Y1.03%
OM growth 3Y-3.68%
OM growth 5Y-1.89%
PM growth 3Y-9.69%
PM growth 5Y-1.78%
GM growth 3Y-0.89%
GM growth 5Y0.39%
F-Score5
Asset Turnover1.05
Health
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF 5.28
Debt/EBITDA 0.73
Cap/Depr 52.89%
Cap/Sales 4.76%
Interest Coverage 250
Cash Conversion 54.98%
Profit Quality 103.99%
Current Ratio 1.35
Quick Ratio 0.96
Altman-Z N/A
F-Score5
WACC6.26%
ROIC/WACC1.09
Cap/Depr(3y)107.61%
Cap/Depr(5y)100.02%
Cap/Sales(3y)9.74%
Cap/Sales(5y)9.61%
Profit Quality(3y)66.21%
Profit Quality(5y)65.11%
High Growth Momentum
Growth
EPS 1Y (TTM)-30.27%
EPS 3Y-3.83%
EPS 5Y5.12%
EPS Q2Q%-198.51%
EPS Next Y-83.94%
EPS Next 2Y-22.77%
EPS Next 3Y-10.58%
EPS Next 5Y-0.33%
Revenue 1Y (TTM)-1.1%
Revenue growth 3Y6.55%
Revenue growth 5Y7.05%
Sales Q2Q%-4.39%
Revenue Next Year-5.99%
Revenue Next 2Y-2.46%
Revenue Next 3Y-0.75%
Revenue Next 5Y2.96%
EBIT growth 1Y-21.15%
EBIT growth 3Y2.63%
EBIT growth 5Y5.02%
EBIT Next Year-6.65%
EBIT Next 3Y11.87%
EBIT Next 5Y16.13%
FCF growth 1Y431.7%
FCF growth 3Y-8.36%
FCF growth 5Y11.7%
OCF growth 1Y-30.9%
OCF growth 3Y-0.33%
OCF growth 5Y7.21%

DR ING HC F PORSCHE AG / P911.DE FAQ

Can you provide the ChartMill fundamental rating for DR ING HC F PORSCHE AG?

ChartMill assigns a fundamental rating of 5 / 10 to P911.DE.


What is the valuation status of DR ING HC F PORSCHE AG (P911.DE) stock?

ChartMill assigns a valuation rating of 5 / 10 to DR ING HC F PORSCHE AG (P911.DE). This can be considered as Fairly Valued.


Can you provide the profitability details for DR ING HC F PORSCHE AG?

DR ING HC F PORSCHE AG (P911.DE) has a profitability rating of 7 / 10.


Can you provide the PE and PB ratios for P911 stock?

The Price/Earnings (PE) ratio for DR ING HC F PORSCHE AG (P911.DE) is 10.13 and the Price/Book (PB) ratio is 0.8.


How financially healthy is DR ING HC F PORSCHE AG?

The financial health rating of DR ING HC F PORSCHE AG (P911.DE) is 5 / 10.